|
1
|
Nishioka T, Eustace A and West C: Lysyl
oxidase: From basic science to future cancer treatment. Cell Struct
Funct. 37:75–80. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fong SF, Dietzsch E, Fong KS, Hollosi P,
Asuncion L, He Q, Parker MI and Csiszar K: Lysyl oxidase-like 2
expression is increased in colon and esophageal tumors and
associated with less differentiated colon tumors. Genes Chromosomes
Cancer. 46:644–655. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin ZY, Chuang YH and Chuang WL:
Cancer-associated fibroblasts up-regulate CCL2, CCL26, IL6 and
LOXL2 genes related to promotion of cancer progression in
hepatocellular carcinoma cells. Biomed Pharmacother. 66:525–529.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peinado H, Moreno-Bueno G, Hardisson D,
Pérez-Gómez E, Santos V, Mendiola M, de Diego JI, Nistal M,
Quintanilla M, Portillo F and Cano A: Lysyl oxidase-like 2 as a new
poor prognosis marker of squamous cell carcinomas. Cancer Res.
68:4541–4550. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ahn SG, Dong SM, Oshima A, Kim WH, Lee HM,
Lee SA, Kwon SH, Lee JH, Lee JM, Jeong J, et al: LOXL2 expression
is associated with invasiveness and negatively influences survival
in breast cancer patients. Breast Cancer Res Treat. 141:89–99.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kasashima H, Yashiro M, Kinoshita H,
Fukuoka T, Morisaki T, Masuda G, Sakurai K, Kubo N, Ohira M and
Hirakawa K: Lysyl oxidase-like 2 (LOXL2) from stromal fibroblasts
stimulates the progression of gastric cancer. Cancer Lett.
354:438–446. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Barker HE, Bird D, Lang G and Erler JT:
Tumor-secreted LOXL2 activates fibroblasts through FAK signaling.
Mol Cancer Res. 11:1425–1436. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barker HE, Chang J, Cox TR, Lang G, Bird
D, Nicolau M, Evans HR, Gartland A and Erler JT: LOXL2-mediated
matrix remodeling in metastasis and mammary gland involution.
Cancer Res. 71:1561–1572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vadasz Z, Kessler O, Akiri G,
Gengrinovitch S, Kagan HM, Baruch Y, Izhak OB and Neufeld G:
Abnormal deposition of collagen around hepatocytes in Wilson's
disease is associated with hepatocyte specific expression of lysyl
oxidase and lysyl oxidase like protein-2. J Hepatol. 43:499–507.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wong CC, Tse AP, Huang YP, Zhu YT, Chiu
DK, Lai RK, Au SL, Kai AK, Lee JM, Wei LL, et al: Lysyl
oxidase-like 2 is critical to tumor microenvironment and metastatic
niche formation in hepatocellular carcinoma. Hepatology.
60:1645–1658. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chien JW, Richards TJ, Gibson KF, Zhang Y,
Lindell KO, Shao L, Lyman SK, Adamkewicz JI, Smith V, Kaminski N
and O'Riordan T: Serum lysyl oxidase-like 2 levels and idiopathic
pulmonary fibrosis disease progression. Eur Respir J. 43:1430–1438.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Van Bergen T, Marshall D, Van de Veire S,
Vandewalle E, Moons L, Herman J, Smith V and Stalmans I: The role
of LOX and LOXL2 in scar formation after glaucoma surgery. Invest
Ophthalmol Vis Sci. 54:5788–5796. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Barry-Hamilton V, Spangler R, Marshall D,
McCauley S, Rodriguez HM, Oyasu M, Mikels A, Vaysberg M, Ghermazien
H, Wai C, et al: Allosteric inhibition of lysyl oxidase-like-2
impedes the development of a pathologic microenvironment. Nat Med.
16:1009–1017. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Meissner EG, McLaughlin M, Matthews L,
Gharib AM, Wood BJ, Levy E, Sinkus R, Virtaneva K, Sturdevant D,
Martens C, et al: Simtuzumab treatment of advanced liver fibrosis
in HIV and HCV-infected adults: Results of a 6-month open-label
safety trial. Liver Int. 36:1783–1792. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saleem MA, O'Hare MJ, Reiser J, Coward RJ,
Inward CD, Farren T, Xing CY, Ni L, Mathieson PW and Mundel P: A
conditionally immortalized human podocyte cell line demonstrating
nephrin and podocin expression. J Am Soc Nephrol. 13:630–638.
2002.PubMed/NCBI
|
|
16
|
Long DA, Woolf AS, Suda T and Yuan HT:
Increased renal angiopoietin-1 expression in folic acid-induced
nephrotoxicity in mice. J Am Soc Nephrol. 12:2721–2731.
2001.PubMed/NCBI
|
|
17
|
Stallons LJ, Whitaker RM and Schnellmann
RG: Suppressed mitochondrial biogenesis in folic acid-induced acute
kidney injury and early fibrosis. Toxicol Lett. 224:326–332. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Meng XM, Nikolic-Paterson DJ and Lan HY:
TGF-beta: The master regulator of fibrosis. Nat Rev Nephrol.
12:325–338. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Marek I, Lichtneger T, Cordasic N, Hilgers
KF, Volkert G, Fahlbusch F, Rascher W, Hartner A and
Menendez-Castro C: Alpha8 integrin (Itga8) signalling attenuates
chronic renal interstitial fibrosis by reducing fibroblast
activation, not by interfering with regulation of cell turnover.
PLoS One. 11:e01504712016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sumual S, Saad S, Tang O, Yong R, McGinn
S, Chen XM and Pollock CA: Differential regulation of Snail by
hypoxia and hyperglycemia in human proximal tubule cells. Int J
Biochem Cell Biol. 42:1689–1697. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Meng XM, Nikolic-Paterson DJ and Lan HY:
Inflammatory processes in renal fibrosis. Nat Rev Nephrol.
10:493–503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Meng XM, Huang XR, Xiao J, Chen HY, Zhong
X, Chung AC and Lan HY: Diverse roles of TGF-b receptor II in renal
fibrosis and inflammation in vivo and in vitro. J Pathol.
227:175–188. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mack M and Yanagita M: Origin of
myofibroblasts and cellular events triggering fibrosis. Kidney Int.
87:297–307. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xiao L, Wang M, Yang S, Liu F and Sun L: A
glimpse of the pathogenetic mechanisms of Wnt/b-catenin signaling
in diabetic nephropathy. Biomed Res Int. 2013:9870642013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pang M, Wang H, Rao P, Zhao Y, Xie J, Cao
Q, Wang Y, Wang YM, Lee VW, Alexander SI, et al: Autophagy links
beta-catenin and Smad signaling to promote epithelial-mesenchymal
transition via upregulation of integrin linked kinase. Int J
Biochem Cell Biol. 76:123–134. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sethi A, Mao W, Wordinger RJ and Clark AF:
Transforming growth factor-beta induces extracellular matrix
protein cross-linking lysyl oxidase (LOX) genes in human trabecular
meshwork cells. Invest Ophthalmol Vis Sci. 52:5240–5250. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Voloshenyuk TG, Landesman ES, Khoutorova
E, Hart AD and Gardner JD: Induction of cardiac fibroblast lysyl
oxidase by TGF-b1 requires PI3K/Akt, Smad3, and MAPK signaling.
Cytokine. 55:90–97. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Neelisetty S, Alford C, Reynolds K,
Woodbury L, Nlandu-Khodo S, Yang H, Fogo AB, Hao CM, Harris RC,
Zent R and Gewin L: Renal fibrosis is not reduced by blocking
transforming growth factor-b signaling in matrix-producing
interstitial cells. Kidney Int. 88:503–514. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim MG, Kim SC, Ko YS, Lee HY, Jo SK and
Cho W: The role of M2 macrophages in the progression of chronic
kidney disease following acute kidney injury. PLoS One.
10:e01439612015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chang JW, Pardo V, Sageshima J, Chen L,
Tsai HL, Reiser J, Wei C, Ciancio G, Burke GW III and Fornoni A:
Podocyte foot process effacement in postreperfusion allograft
biopsies correlates with early recurrence of proteinuria in focal
segmental glomerulosclerosis. Transplantation. 93:1238–1244. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Alachkar N, Wei C, Arend LJ, Jackson AM,
Racusen LC, Fornoni A, Burke G, Rabb H, Kakkad K, Reiser J and
Estrella MM: Podocyte effacement closely links to suPAR levels at
time of posttransplantation focal segmental glomerulosclerosis
occurrence and improves with therapy. Transplantation. 96:649–656.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wharram BL, Goyal M, Wiggins JE, Sanden
SK, Hussain S, Filipiak WE, Saunders TL, Dysko RC, Kohno K, Holzman
LB and Wiggins RC: Podocyte depletion causes glomerulosclerosis:
Diphtheria toxin-induced podocyte depletion in rats expressing
human diphtheria toxin receptor transgene. J Am Soc Nephrol.
16:2941–2952. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Maezawa Y, Takemoto M and Yokote K: Cell
biology of diabetic nephropathy: Roles of endothelial cells,
tubulointerstitial cells and podocytes. J Diabetes Investig.
6:3–15. 2015. View Article : Google Scholar : PubMed/NCBI
|
